Prognostic Groups for Smoldering Multiple Myeloma

Are you evaluating a patient who has just been diagnosed as having smoldering myeloma?

Yes

Serum monoclonal protein

Percent plasma cells in the bone marrow (enter from 0 to 100)

Is monoclonal IgA present?

Yes

Are light chains present in the urine?

Yes

Are the levels of normal immunoglobulins normal or elevated?

Yes

Does the bone marrow show plasma cells in sheets?

Yes

Please fill out required fields.

Data complete?

Evaluation appropriate?

Prognostic group

Cumulative probability of progression to active myeloma or amyloidosis within 15 years

Additional risk factors present

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Interpretation and Description

References

Next Steps in Evaluation

Selection
- Asymptomatic Multiple Myeloma Model for Predicting Risk of Progression

Response To Therapy
- Criteria for Evaluating Response of Multiple Myeloma to Therapy

Evaluation

Results

Please fill out required fields.

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Therapy

Monitoring

Specialty

Objective

ICD-10

Prognostic Groups for Smoldering (Asymptomatic) Multiple Myeloma

Purpose: To evaluate a patient with smoldering (asymptomatic) myeloma based on the prognostic groups of Kyle et al.

Evaluation

Results

Please fill out required fields.

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Therapy

Monitoring

Specialty

Objective

ICD-10